Recent Posts
News•Feb 26, 2026
Medtech M&A Starts Off Strong in 2026
Medtech M&A kicks off 2026 with several multibillion‑dollar deals. Boston Scientific announced a $14.5 billion acquisition of Penumbra, while Danaher disclosed a $9.9 billion purchase of Masimo. At the same time, major divestitures are underway, including BD’s planned $17.5 billion sale of its biosciences and diagnostics units, Medtronic’s upcoming diabetes spinoff, and Johnson & Johnson’s orthopedics carve‑out. The flurry of activity signals a rapid consolidation phase across vascular, diagnostics and orthopedics segments.
By MedTech Dive
News•Feb 26, 2026
FDA Warns Beta Bionics on Unreported Complaints, Insulin Pump Changes
Beta Bionics received an FDA warning letter citing failure to report serious adverse events, unreported software and cybersecurity changes, and hardware defects in its iLet Bionic Pancreas system. The agency highlighted delayed reporting of hypoglycemia and hyperglycemia incidents, a five‑minute...
By MedTech Dive
News•Feb 25, 2026
Labcorp Expands PathAI Pact to Roll Out Digital Pathology Platform in US
Labcorp announced an expanded partnership with PathAI to deploy the AISight Dx digital pathology platform across its U.S. anatomic pathology labs and hospital sites. The AI‑enabled software will allow pathologists to scan, annotate and diagnose slides digitally, aiming to cut turnaround...
By MedTech Dive
News•Feb 23, 2026
Guardant Buys MetaSight for $59M Upfront to Acquire Blood Test Tech
Guardant Health has agreed to acquire Israel‑based MetaSight Diagnostics for $59 million in cash, with up to $90 million in performance‑based earn‑outs. MetaSight brings mass‑spectrometry‑driven multi‑omics liquid‑biopsy technology, targeting colorectal cancer, liver fibrosis, myocardial infarction, and diabetic kidney disease. The deal broadens...
By MedTech Dive
News•Feb 23, 2026
Transforming Epilepsy Care: How Innovative Implantable Neurotechnology Offers New Hope
PRECISIS GmbH’s EASEE® epicranial neurostimulation system offers a minimally invasive alternative for drug‑resistant focal epilepsy. The implant, positioned under the scalp atop the skull, delivers targeted electrical pulses without opening the skull, achieving a median 68% seizure reduction over two...
By MedTech Dive
Deals•Feb 23, 2026
Guardant Health Acquires MetaSight Diagnostics for $59M Upfront
Guardant Health announced the acquisition of MetaSight Diagnostics for $59 million in upfront cash, with up to $90 million in additional contingent payments tied to commercial performance and regulatory approvals. The deal expands Guardant’s multi‑disease detection pipeline beyond oncology, adding MetaSight’s mass‑spectrometry...
MedTech Dive
News•Feb 20, 2026
Senseonics Launches Automated Insulin Dosing System with 1-Year CGM
Senseonics and Sequel Med Tech have launched an automated insulin‑delivery system that pairs the year‑long Eversense 365 implantable CGM with Sequel’s twiist pump. The integration, delayed to Q4 2025, marks the first AID solution using a one‑year sensor, contrasting with competitors’ 15‑day...
By MedTech Dive
News•Feb 19, 2026
FDA Issues Early Alert on Trividia Glucometer Issue Linked to 114 Injuries
The FDA issued an early alert after linking Trividia Health’s True Metrix glucometers to 114 injuries and one death. The alert cites an E‑5 error code that appears when blood glucose exceeds 600 mg/dL or when a test‑strip fault occurs, potentially...
By MedTech Dive
News•Feb 18, 2026
Medline Addresses Bed Fire Risk Linked to Death
Medline is revising usage instructions for its home‑care adjustable beds after the FDA documented safety incidents involving hand‑control pendants that sparked, melted or ignited, and entrapment hazards from third‑party accessories. The agency recorded 12 injuries and two deaths—one fire‑related and...
By MedTech Dive
News•Feb 17, 2026
Medtronic Completes First Hugo Case in the US
Medtronic performed the first U.S. Hugo robotic surgery—a prostatectomy at the Cleveland Clinic—shortly after receiving FDA clearance. The system, already CE‑marked in Europe, is being installed at Duke University Hospital and Atrium Health, marking its initial U.S. footprint. CEO Geoff...
By MedTech Dive
News•Feb 13, 2026
Dexcom Seeks Expanded Medicare Coverage of CGMs for Type 2 Diabetes
Dexcom is lobbying the Centers for Medicare & Medicaid Services for expanded coverage of its continuous glucose monitors (CGMs) for Type 2 diabetes patients who do not use insulin. The company estimates the change could make CGMs available to roughly 12 million...
By MedTech Dive
News•Feb 13, 2026
Siemens Healthineers, Mayo Clinic Partner on Neurodegenerative Disease, Cancer
Siemens Healthineers and Mayo Clinic have expanded their strategic partnership to accelerate AI‑driven imaging and interventional technologies for neurodegenerative disease, prostate cancer, and metastatic liver tumors. The agreement emphasizes AI‑enabled ultra‑high‑field MRI protocols for Alzheimer’s detection, AI tools to reduce...
By MedTech Dive
News•Feb 13, 2026
Novocure Wins FDA Approval to Treat Pancreatic Cancer with Electric Fields
Novocure received FDA clearance for its Optune Pax tumor‑treating‑field device in locally advanced pancreatic cancer, marking the company’s first indication beyond brain tumors. The pivotal trial of 571 patients showed a statistically significant two‑month overall‑survival gain (16.2 vs 14.2 months) when the device was...
By MedTech Dive
News•Feb 12, 2026
Neurent Raises $74M to Commercialize Treatment for Nasal Condition
Neurent Medical announced a €62.5 million ($74 million) Series C round to accelerate commercialization of its Neuromark radio‑frequency device for chronic rhinitis. The FDA has cleared the latest version of Neuromark, which delivers low‑power energy to disrupt nasal nerve signals and has demonstrated...
By MedTech Dive
Deals•Feb 12, 2026
Neurent Medical Raises $74M in Series C Round to Commercialize Chronic Rhinitis Device
Neurent Medical announced a €62.5 million ($74 million) Series C financing to accelerate commercialization of its Neuromark radio‑frequency device for chronic rhinitis. The round was led by MVM Partners with participation from Sofinnova Partners, EQT Life Sciences, Atlantic Bridge, Fountain Healthcare Partners and...
MedTech Dive
News•Feb 11, 2026
Zimmer Plans US Salesforce Reorganization
Zimmer Biomet announced a U.S. salesforce reorganization aimed at creating a fully dedicated, product‑specialized team of 2,500 reps. The shift targets high‑growth segments such as sports medicine, trauma, robotics, and ambulatory surgery centers, with one‑third of the transition already complete....
By MedTech Dive
Deals•Feb 11, 2026
Labcorp Closes $250M Acquisition of Empire City Laboratories Assets
Labcorp announced the closing of its acquisition of assets from Empire City Laboratories, paying $165 million upfront with up to $85 million in milestone payments. The $250 million deal expands Labcorp’s patient service center network in New York and positions it as the integrated...
MedTech Dive
News•Feb 10, 2026
Baxter Cuts Roughly 90 Jobs at IV Solutions Plant that Recovered From Hurricane Helene
Baxter International announced it is cutting roughly 90 positions at its Marion, North Carolina IV solutions plant, representing about 3% of the site’s workforce. The facility, which supplies roughly 60% of U.S. IV fluids, recovered from Hurricane Helene damage but...
By MedTech Dive